AMRN
Amarin Corp. Plc
NASDAQ · Healthcare · Biotechnology · IE
$11.53
+1.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.55x
- Price / sales
- 1.31x
- Price / cash flow
- 4.95x
Enterprise value
- Enterprise value
- -$65.8M
- EV / sales
- -0.35x
- EV / EBITDA
- 3.35x
- EV / EBIT
- 1.97x
- Market cap
- $243.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026